BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9848882)

  • 1. Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women.
    Rosenson RS; Tangney CC; Mosca LJ
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1902-5. PubMed ID: 9848882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.
    Basaria S; Nguyen T; Rosenson RS; Dobs AS
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):209-14. PubMed ID: 12153599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of hormone replacement therapy on hemorheology in postmenopausal women].
    Wang Y; Xing S; Dong X
    Zhonghua Fu Chan Ke Za Zhi; 2001 Aug; 36(8):476-8. PubMed ID: 11758183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
    Espeland MA; Marcovina SM; Miller V; Wood PD; Wasilauskas C; Sherwin R; Schrott H; Bush TL
    Circulation; 1998 Mar; 97(10):979-86. PubMed ID: 9529266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers.
    Mancini F; Persico N; Genazzani AD; Volpe A; Battaglia C; De Aloysio D
    Gynecol Endocrinol; 2005 Apr; 20(4):221-6. PubMed ID: 16019365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
    Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hormone replacement therapy on hemostatic cardiovascular risk factors.
    Andersen LF; Gram J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):283-9. PubMed ID: 9988788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal women.
    Fröhlich M; Schunkert H; Hense HW; Tropitzsch A; Hendricks P; Döring A; Riegger GA; Koenig W
    Br J Haematol; 1998 Mar; 100(3):577-81. PubMed ID: 9504644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension.
    Modena MG; Rossi R; Muia N; Origliani G; Rombolà O; Molinari R
    G Ital Cardiol; 1998 Jun; 28(6):636-44. PubMed ID: 9672776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women.
    Kawano H; Motoyama T; Hirai N; Yoshimura T; Kugiyama K; Ogawa H; Okamura H; Yasue H
    Am J Cardiol; 2001 Jan; 87(2):238-40, A9. PubMed ID: 11152852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
    Kanaya AM; Herrington D; Vittinghoff E; Lin F; Grady D; Bittner V; Cauley JA; Barrett-Connor E;
    Ann Intern Med; 2003 Jan; 138(1):1-9. PubMed ID: 12513038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal hormone replacement therapy and Doppler findings in normal and overweight postmenopausal patients.
    Persico N; Mancini F; Artini PG; Regnani G; Volpe A; de Aloysio D; Battaglia C
    Gynecol Endocrinol; 2004 Nov; 19(5):274-81. PubMed ID: 15726916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins.
    Haines CJ; Chung TK; Masarei JR; Tomlinson B; Lau JT
    Atherosclerosis; 1996 Jan; 119(2):215-22. PubMed ID: 8808498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement.
    Kublickiene K; Fu XD; Svedas E; Landgren BM; Genazzani AR; Simoncini T
    J Clin Endocrinol Metab; 2008 May; 93(5):1874-83. PubMed ID: 18319309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.